SCHEMBL25820606

SCHEMBL25820606

Cc1c(Nc2ccnc3ccc(C#N)cc23)cccc1C(=O)Nc1cccc(Nc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 6/20 0.51
RXFP1 Q9HBX9 2/20 0.46
HTT P42858 1/20 0.45
DNMT3A Q9Y6K1 4/20 0.45
MAPKAPK2 P49137 2/20 0.45
GAK O14976 1/20 0.44
RIPK2 O43353 1/20 0.44
COQ8A Q8NI60 1/20 0.44
NLK Q9UBE8 1/20 0.44
DNMT3L Q9UJW3 3/20 0.44
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
EHMT1 Q9H9B1 2/20 0.42
NR1H4 Q96RI1 1/20 0.42
GRM4 Q14833 1/20 0.42
BRAF P15056 2/20 0.42
EGFR P00533 1/20 0.42
RAF1 P04049 1/20 0.41
LRRK2 Q5S007 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25487272 0.95 DNMT1 (0.48) DNMT1RXFP1HTTDNMT3AMAPKAPK2
SCHEMBL25820621 0.89 DNMT1 (0.47) DNMT1RXFP1HTTDNMT3AMAPKAPK2
SCHEMBL24006175 0.89 DNMT1 (0.49) DNMT1RXFP1DNMT3AMAPKAPK2GAK
SCHEMBL25820605 0.88 BRAF (0.51) DNMT1HTTDNMT3AMAPKAPK2GAK
SCHEMBL25820643 0.86 DNMT1 (0.54) DNMT1DNMT3AMAPKAPK2GAKDNMT3L
SCHEMBL25820602 0.85 DNMT1 (0.51) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL25826555 0.84 MAPT (0.46) DNMT1RXFP1HTTDNMT3AMAPKAPK2
SCHEMBL24010972 0.84 DNMT1 (0.64) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL24003789 0.84 DNMT1 (0.59) DNMT1DNMT3AMAPKAPK2GAKRIPK2
SCHEMBL25820730 0.84 DNMT1 (0.64) DNMT1DNMT3AMAPKAPK2GAKRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885RXFP1 4004/4885HTT 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.